Turn Therapeutics Inc.
TTRX
$3.53
$0.030.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -185.74% | -101.46% | -101.46% | -59.66% | |
| Total Depreciation and Amortization | 13.22% | 8.70% | 8.70% | 45.78% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -84.15% | 479.88% | 479.88% | 800.28% | |
| Change in Net Operating Assets | 4,194.22% | 171.49% | 171.49% | -62.78% | |
| Cash from Operations | -56.42% | -43.89% | -43.89% | -2.90% | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -106.44% | 34.02% | 34.02% | -182.47% | |
| Cash from Investing | -106.44% | 34.02% | 34.02% | -182.47% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 83.80% | 925.81% | 925.81% | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 83.80% | 925.81% | 925.81% | -- | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 12.89% | 882.91% | 882.91% | 74.76% | |